CME GROUP INC. (CME) Form 10-Q — Oct 23, 2026
CME Group's Q3 2026 10-Q shows revenue of $1.74 billion, up 13% year over year, with net income of $1.04 billion and diluted EPS of $2.89, up 16%, driven by 16% growth in total contract volume to 1.88 billion contracts. All major asset classes grew, led by equity indexes ADV up 23% and foreign exchange up 19%, though the average rate per contract slipped 3% to $0.679 on mix and incentives. Operating margin expanded to 65.7% from 63.3%. The company returned significant capital: $0.5 billion of buybacks in Q3 at an average of $255.81 per share with $1.0 billion remaining under the $3 billion program, plus $10.05 per share in dividends paid over nine months.
Key figures
- Eps
- 2.89
- Revenue Yoy
- 13%
- Cash Position
- 2198500000
- Shares Outstanding
- 357930746
- Aggregate adv q3
- 29,445 thousand
- Q3 buyback total
- $0.5 billion at avg $255.81
- Q3 buyback shares
- 2047234
- Q3 2025 diluted eps
- 2.49
- Effective tax rate q3
- 23.5%
- Nine month net income
- 3233000000
- Nine month diluted eps
- 8.96
- Q3 2026 operating margin
- 65.7%
- Total contract volume q3
- 1,884.5 million
- Average rate per contract q3
- 0.679
- Dividends per share nine months
- 10.05
- Remaining buyback authorization
- 1000000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.